Chronic inflammatory demyelinating polyneuropathy

0Citations
Citations of this article
487Readers
Mendeley users who have this article in their library.

Abstract

In this review, we discuss chronic inflammatory demyelinating polyneuropathy (CIDP), which is a disease with proximal and distal weakness and sensory disturbances resulting in impaired daily activity. The diagnosis is based on the clinical presentation and electrophysiology demonstrating demyelination in the peripheral nerves. CIDP can be successfully treated with immunoglobulin, glucocorticoids or plasma exchange, and during the latest decade, immunoglobulin has been administered subcutaneously improving patients’ flexibility and autonomy. By time, 30% of the patients will remit, and maintenance treatment will no longer be necessary.

Cite

CITATION STYLE

APA

Markvardsen, L. K., Harbo, T., Holbech, J. V., Tankisi, H., Christiansen, I., Olsen, N. K., … Andersen, H. (2020). Chronic inflammatory demyelinating polyneuropathy. Ugeskrift for Laeger, 181(9), 2–6. https://doi.org/10.47363/jmhc/2022(4)196

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free